Superworth

Alkermes plc. EV/EBIT ALKS

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Nov 2, 2026
71.4×
3-year median
12.0×
Against its 3-year history
95th
percentile: 0 is its lowest day, 100 its highest
3-year range
7.4× to 77.6×
Peer median
58.4×

Alkermes plc.'s EV/EBIT is 71.4× as of Nov 2, 2026.

That is above its 3-year median of 12.0×, higher than on 95% of days in the last 3 years.

Over that time it ranged from 7.4× in May 2024 to 77.6× in Aug 2026.

The median for 10 large drugmakers of a similar size is 58.4×.

EV/EBIT over time

The dashed line is the 3-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far71.4×10.1×77.6×
202510.2×8.8×14.4×
202413.3×7.4×14.3×
202311.7×9.8×23.2×
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
2020n/m a value too high to mean anything
2019n/m a value too high to mean anything
2018n/m a value too high to mean anything
2017n/m a value too high to mean anything
2016n/m a value too high to mean anything
2015n/m a value too high to mean anything
2014n/m a value too high to mean anything
201385.4×57.5×151×
2012126×126×137×

Against its peers

Companies in Drug Manufacturers - General nearest Alkermes plc.'s size, closest first, today.

Where Alkermes plc. ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Alkermes plc.

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.